BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Genç B, Gautam M, Gözütok Ö, Dervishi I, Sanchez S, Goshu GM, Koçak N, Xie E, Silverman RB, Özdinler PH. Improving mitochondria and ER stability helps eliminate upper motor neuron degeneration that occurs due to mSOD1 toxicity and TDP-43 pathology. Clin Transl Med 2021;11:e336. [PMID: 33634973 DOI: 10.1002/ctm2.336] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheng L, Su Y, Zhi K, Xie Y, Zhang C, Meng X. Conditional deletion of MAD2B in forebrain neurons enhances hippocampus-dependent learning and memory in mice. Front Cell Neurosci 2022;16:956029. [DOI: 10.3389/fncel.2022.956029] [Reference Citation Analysis]
2 Genç B, Gautam M, Helmold BR, Koçak N, Günay A, Goshu GM, Silverman RB, Hande Ozdinler P. NU-9 improves health of hSOD1G93A mouse upper motor neurons in vitro, especially in combination with riluzole or edaravone. Sci Rep 2022;12. [DOI: 10.1038/s41598-022-09332-4] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Kon T, Mori F, Tanji K, Miki Y, Nishijima H, Nakamura T, Kinoshita I, Suzuki C, Kurotaki H, Tomiyama M, Wakabayashi K. Accumulation of Nonfibrillar TDP-43 in the Rough Endoplasmic Reticulum Is the Early-Stage Pathology in Amyotrophic Lateral Sclerosis. J Neuropathol Exp Neurol 2022;81:271-81. [PMID: 35294549 DOI: 10.1093/jnen/nlac015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Gautam M, Gunay A, Chandel NS, Ozdinler PH. Mitochondrial dysregulation occurs early in ALS motor cortex with TDP-43 pathology and suggests maintaining NAD+ balance as a therapeutic strategy. Sci Rep 2022;12:4287. [PMID: 35277554 DOI: 10.1038/s41598-022-08068-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
5 Genç B, Jara JH, Sanchez SS, Lagrimas AKB, Gözütok Ö, Koçak N, Zhu Y, Hande Özdinler P. Upper motor neurons are a target for gene therapy and UCHL1 is necessary and sufficient to improve cellular integrity of diseased upper motor neurons. Gene Ther 2021. [PMID: 34853443 DOI: 10.1038/s41434-021-00303-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 González LF, Bevilacqua LE, Naves R. Nanotechnology-Based Drug Delivery Strategies to Repair the Mitochondrial Function in Neuroinflammatory and Neurodegenerative Diseases. Pharmaceutics 2021;13:2055. [PMID: 34959337 DOI: 10.3390/pharmaceutics13122055] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Haidar M, Viden A, Turner BJ. Advances in Gene Delivery Methods to Label and Modulate Activity of Upper Motor Neurons: Implications for Amyotrophic Lateral Sclerosis. Brain Sci 2021;11:1112. [PMID: 34573134 DOI: 10.3390/brainsci11091112] [Reference Citation Analysis]